Clinical Trial Update: Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describing a neuroimaging study of bupropion in patients with major depressive disorder, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Wellbutrin (bupropion)

Snippet

Sponsor: Ewha Womans University | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED